B030 - Observational study: Conditions of use of duloxetine in France 
Head :
Laboratoire , Eli Lilly France
Last update : 01/01/2020 | Version : 1 | ID : 80
| General | |
| Identification | |
| Detailed name | Observational study: Conditions of use of duloxetine in France |
| Sign or acronym | B030 |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL N°909021 |
| General Aspects | |
| Medical area |
Psychology and psychiatry |
| Others (details) | Depression |
| Keywords | Pharmacy, appropriate use, duloxetine, conditions of use |
| Scientific investigator(s) (Contact) | |
| Name of the director | Laboratoire |
| fr_mail_pharmacoepi@lilly.com | |
| Unit | Eli Lilly France |
| Collaborations | |
| Funding | |
| Funding status |
Private |
| Details | Eli Lilly and Company |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | Eli Lilly |
| Organisation status |
Private |
| Additional contact | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Not-repeated cross-sectional studies (except case control studies) |
| Database recruitment is carried out by an intermediary |
A population file |
| Database recruitment is is made on the basis of: |
Medication(s) taken |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. | Patients recruited by pharmacies. Random selection of pharmacies using professional listing. Stratification by region and by zone (urban/town). |
| Database objective | |
| Main objective |
Primary objective: evaluate the conditions for use of duloxetine in routine practice; Secondary objectives: characteristics of the patients treated by duloxetine, profiles of duloxetine prescribers, characteristics of treatment. |
| Inclusion criteria | Patient receiving duloxetine in a pharmacy regardless of the indication, whether treatment initiation or renewal |
| Population type | |
| Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
| Population covered |
Sick population |
| Gender |
Male Woman |
| Geography area |
National |
| Detail of the geography area | National |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 2009 |
| Date of last collection (YYYY or MM/YYYY) | 2010 |
| Size of the database | |
| Size of the database (number of individuals) |
< 500 individuals |
| Details of the number of individuals | 294 |
| Data | |
| Database activity |
Data collection completed |
| Type of data collected |
Clinical data |
| Clinical data (detail) |
Direct physical measures |
| Presence of a biobank |
No |
| Health parameters studied |
Health event/morbidity |
| Procedures | |
| Data collection method | Study data collection form |
| Participant monitoring |
No |
| Links to administrative sources |
No |
| Promotion and access | |
| Promotion | |
| Access | |
| Terms of data access (charter for data provision, format of data, availability delay) | Report and publications |
| Access to aggregated data |
Access on specific project only |
| Access to individual data |
Access on specific project only |
